Table 2 Baseline characteristics of patients in the included studies
Study ID | Study Groups | Sample | Age | BMI, Kg/m2 | Sex, Female | NYHA classification | LVEF | LVEDD, cm | Comorbidities | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
III | IV | AF | Diabetes | HTN | COPD | Renal disease | Liver disease | CHF | PVD | History of MI | History of stroke or TIA | History of CAD | Previous CABG | Previous PCI | ||||||||
Alharbi et al. 2020 [19] | TAVI | 915 | 77 (12.62) | – | 265 (29.0) | – | – | – | – | – | 115 (12.6) | 410 (44.8) | 230 (25.1) | 365 (39.9) | 35 (3.8) | 730 (79.8) | 200 (21.9) | – | – | 575 (62.8) | – | – |
SAVR | 1390 | 73.67 (9.65) | – | 400 (28.8) | – | – | – | – | – | 160 (11.5) | 560 (40.3) | 320 (23.0) | 465 (33.5) | 55 (4.0) | 1060 (76.3) | 350 (25.2) | – | – | 830 (59.7) | – | – | |
Mentias et al. 2023 [18] | TAVI | 1147 | 75.6 (6.8) | – | 459 (40) | – | – | – | – | 321 (28) | 310 (27) | 975 (85) | – | 206 (18) | 46 (4) | 734 (64) | 298 (26) | – | 92 (8) | 688 (60) | – | – |
SAVR | 9880 | 75.6 (5.7) | – | 3952 (40) | – | – | – | – | 2766 (28) | 2668 (27) | 8483 (85) | – | 1796 (18) | 395 (4) | 6323 (64) | 2569 (26) | – | 790 (8) | 5928 (60) | – | – | |
Oettinger et al. 2023 [31] | TAVI | 836 | 76.79 (8.77) | – | 288 (34.45) | 432 (51.67) | – | – | 394 (47.12) | 156 (18.66) | 571 (68.3) | 157 (18.78) | 10 (1.2) | – | – | 69 (8.25) | 8 (0.96) | – | 386 (46.17) | 188 (22.49) |  | |
SAVR | 4025 | 62.75 (13.58) | – | 1023 (25.42) | 1361 (33.81) | – | – | 1790 (44.47) | 491 (12.2) | 2350 (58.4) | 288 (7.16) | 69 (1.71) | – | – | 114 (2.83) | 23 (0.57) | – | 588 (14.61) | 61 (1.52) | – | ||
Rali et al. 2022 [32] | TAVI | 105 | 67 (6.77) | – | 40 (38.1) | – | – | – | – | 35 (33.3) | 35 (33.3) | 85 (81) | 20 (19) | 30 (28.6) | – | – | – | – | – | 55 (52.4) | – | – |
SAVR | 50 | 61.33 (6.11) | – | 15 (30) | – | – | – | – | 20 (40) | NR | 45 (90) | NR | 30 (60) | – | – | – | – | – | 30 (60) | – | – | |
Stachon et al. 2019 [20] | TAVI | 724 | 77.04 (8.99) | – | 298 (41.16) | 350 (48.34) | – | – | 319 (44.06) | 150 (20.72) | 455 (62.85) | 109 (15.06) | 16 (2.21) | – | – | 77 (10.64) | 12 (1.66) | – | 317 (43.78) | 161 (22.24) | – | |
SAVR | 10,528 | 60.9 (14.1) | – | 2737 (26) | 2653 (25.2) | – | – | 3758 (35.7) | 1284 (12.2) | 5980 (56.8) | 832 (7.9) | 147 (1.4) | – | – | 316 (3) | 53 (0.5) | – | 1063 (10.1) | 253 (2.4) | – | ||
Zhou et al. 2023 [21] | TAVI | 1820 | 70.49 (12.49) | – | 655 (36) | – | – | – | – | – | 287 (15.8) | – | 486 (26.7) | 509 (28) | 95 (5.2) | 1334 (73.3) | 465 (25.5) | 232 (12.7) | 213 (11.7) | – | 202 (11.1) | 206 (11.3) |
SAVR | 1820 | 69.98 (10.41) | – | 650 (35.7) | – | – | – | – | – | 282 (15.5) | – | 489 (26.9) | 505 (27.7) | 96 (5.3) | 1326 (72.9) | 439 (24.1) | 237 (13) | 211 (11.6) | – | 213 (11.7) | 212 (11.6) | |